Clinical Trial

Induced Hypertension in Acute PRogrESsive Perforating Artery Stroke Using Peripheral Dilute noREpinephrine

Study acronym: PRESSURE
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
PRESSURE is a multicenter, prospective, randomized, open, blinded end-point assessed (PROBE) trial, that aims to evaluate the efficacy and safety of drug-induced hypertension using peripheral dilute norepinephrine, in patients with acute ischemic stroke in a perforating artery territory and experiencing early neurological deterioration.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2023-09-22.
Status change: Not Yet Recruiting → Recruiting 2025-01-07
Trial Details
NCT Number NCT06059144
Lead Sponsor University Hospital, Bordeaux
Conditions Stroke, Acute, Stroke, Ischemic
Enrollment 358 participants
Start Date 2024-11-28
Primary Completion 2027-08-28 (estimated)
Study Completion 2027-11-28 (estimated)
Updated on ClinicalTrials.gov 2025-01-09